Coronary
Stent Measurement System
is Licensed in Canada Home-country certification of Medical
Venture's Metricath Gemini
will permit additional international approvals
February 22, 2007 -- Richmond, BC -- Medical Venture Corp.
(TSXV: MEV), a medical devices company specializing in products
for the
vascular
and surgical markets, has received a medical device license from Health Canada
for its Metricath Gemini® vessel measurement system.
Canadian licensing permits Medical Ventures to market and sell the device in Canada for use in angioplasty procedures that treat diseased coronary arteries. The license also grants the product country-of-origin certification, a frequent requirement in seeking broader international regulatory acceptance.
The Metricath Gemini device was approved in Europe in Q3 2006 for all vascular applications and is cleared for use in peripheral (non-coronary) artery procedures in the United States. Medical Ventures is presently engaged in a clinical trial – called “GAAME” – to support its application to the U.S. Food & Drug Administration for the device to be used in the U.S. in coronary arteries.
The Metricath Gemini consists of a dual-balloon catheter and electronic console unit. The device’s low-pressure balloon measures the internal diameter and area of blood vessels and stents, small expandable mesh tubes placed in damaged arteries to help restore blood flow. The Gemini’s high-pressure angioplasty balloon can be used to enlarge vessels or under-deployed stents by expanding the balloon within the artery.
Studies suggest accurately measuring arteries and confirming proper stent deployment during angioplasty can reduce a patient’s likelihood of post-procedure complications, including re-narrowing of vessels and/or blood clotting. The Gemini device uniquely allows doctors to measure and treat diseased arteries with a single catheter.
About Medical Ventures Corp.
Medical Ventures Corp. is a medical device company dedicated to developing products that address clinical needs in the quickly growing vascular and surgical marketplace. MEV products help doctors treat a wide range of health concerns, including cardiovascular disease, hernias and obesity. The company develops and manufactures the patented Metricath® System catheter technology and PeriPatch™, a suite of surgical tissue products. Medical Ventures is also a contract medical devices manufacturer. For more information, please visit www.medical-ventures.com.
Source: Medical Ventures Corp.
(Disclaimer: external
links to news, press releases and other timely information
sources are provided as a service by Angioplasty.Org, which
is not responsible for the content found on any external
sites. Items marked with a ($$) indicate that the external
site normally restricts viewing to paid subscribers. Other
sites may require free registration.
send comments & suggestions
to "info at angioplasty dot org"
Read our Privacy statement.
Angioplasty.Org is an editorially independent informational health
site
which has received unrestricted educational grants from Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
